| Della Louise Hoyle Hinn, MS CCC-SLP | |
|
7001 Loisdale Rd, Suite A, Springfield, VA 22150-1904 | |
| (703) 971-0602 | |
| (703) 971-0606 |
| Full Name | Della Louise Hoyle Hinn |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7001 Loisdale Rd, Springfield, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154692234 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2202006553 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Della Louise Hoyle Hinn, MS CCC-SLP 5829 15th St N, Arlington, VA 22205-2315 Ph: (703) 772-2558 | Della Louise Hoyle Hinn, MS CCC-SLP 7001 Loisdale Rd, Suite A, Springfield, VA 22150-1904 Ph: (703) 971-0602 |
News Archive
Australian researchers will aim to discover the proteins that cause multiple sclerosis (MS), thanks to a new nationwide research effort. The new research project will receive funding of $1 million over four years, starting this year, under the Australian Research Council's Linkage Projects funding scheme and from MS Research Australia (MSRA), the research arm of MS Australia.
Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, a combination of IL2 therapy and activation of patients' immune systems using personalized vaccines made from their own tumor cells has been shown to improve survival rates even more than IL2 alone, according to a new article in Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Questcor Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has informed Questcor that the FDA will require additional time beyond the current action date of September 11, 2010 to complete its review of Questcor's supplemental new drug application for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms.
In one of the first reported cases of its kind, a 3-week-old infant in critical condition recovered from COVID-19 due to rapid recognition and treatment by physicians from McGovern Medical School at The University of Texas Health Science Center at Houston/
Achieving Equity In Health - This policy brief examines the outlining factors that cause disparities in the health care system and focuses on the October issue of the journal, which is devoted to research on the subject.
› Verified 3 days ago
Sarah Wotherspoon Taggart, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6506 Loisdale Rd, Suite 300, Springfield, VA 22150 Phone: 703-924-4100 Fax: 703-922-0638 | |
Mckenzie Leigh Ross, M.S./CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7001a Loisdale Rd, Springfield, VA 22150 Phone: 703-971-0602 | |
Children's Speech And Language Services Of Springfield, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6354 Rolling Mill Pl # 103, Springfield, VA 22152 Phone: 703-866-0344 Fax: 703-866-0233 | |
Meghan Marie Mcnamara, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5427b Backlick Rd, Springfield, VA 22151 Phone: 574-356-6742 | |
Mrs. Rachel Rose Mcadams, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7001a Loisdale Rd, Springfield, VA 22150 Phone: 703-971-0602 | |
Beth Ziegler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8519 Tuttle Rd, Springfield, VA 22152 Phone: 703-451-8041 | |
Daniela Luisa Renfroe, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6506 Loisdale Rd Ste 300, Springfield, VA 22150 Phone: 703-924-4100 |